Skip to content

Superiority of tipranavir / ritonavir confirmed in second salvage study

HAART use in pregnant women associated with premature delivery, but not congenital abnormalities

HIV-positive syphilis patients harder to treat for neurological complications

Hetero withdraws 6 HIV drugs from WHO prequalification list

Children may benefit from a higher dose of nevirapine than recommended by manufacturer

Co-trimoxazole reduces risk of death for children in Zambia, should be given to all children with HIV symptoms, say researchers

Atazanavir/ritonavir shows comparable efficacy to Kaletra at 96 weeks for PI-experienced patients

Rates of TB treatment interruption unaffected by HIV infection or HAART

AZT resistance suppression mutations can also reduce tenofovir resistance, test tube study shows (corrected)